Literature DB >> 3104262

Pharmaceutical aspects. Nasal and depot formulations of leuprolide.

T Shimamoto.   

Abstract

Mesh：

Substances：

Year:  1987        PMID： 3104262

Source DB:  PubMed          Journal:  J Androl        ISSN： 0196-3635


× No keyword cloud information.
  6 in total

Review 1.  Clinical pharmacokinetics of depot leuprorelin.

Authors:  Piero Periti; Teresita Mazzei; Enrico Mini
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

Review 2.  Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release.

Authors:  Nazila Kamaly; Basit Yameen; Jun Wu; Omid C Farokhzad
Journal:  Chem Rev       Date:  2016-02-08       Impact factor: 60.622

Review 3.  Leuprorelin. A review of its pharmacology and therapeutic use in prostatic disorders.

Authors:  P Chrisp; E M Sorkin
Journal:  Drugs Aging       Date:  1991 Nov-Dec       Impact factor: 3.923

4.  Enhancement of nasal delivery of a renin inhibitor in the rat using emulsion formulations.

Authors:  T T Kararli; T E Needham; G Schoenhard; D A Baron; R E Schmidt; B Katz; B Belonio
Journal:  Pharm Res       Date:  1992-08       Impact factor: 4.200

Review 5.  Leuprorelin. A review of its pharmacology and therapeutic use in prostatic cancer, endometriosis and other sex hormone-related disorders.

Authors:  G L Plosker; R N Brogden
Journal:  Drugs       Date:  1994-12       Impact factor: 9.546

Review 6.  Gonadotrophin-releasing hormone agonists. A guide to use and selection.

Authors:  M Filicori
Journal:  Drugs       Date:  1994-07       Impact factor: 9.546
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.